Materials Sodium hyaluronate (CAS: 9004-61-9), gelatin (CAS: 9000-70-8), sodium alginate (CAS: 9005-38-3), tetraethyl orthosilicate (TEOS, CAS: 78-10-4), copper nitrate trihydrate (Cu(NO 3 ) 2 3H 2 O, CAS: 10031-43-3), zinc nitrate hexahydrate (Zn(NO 3 ) 2 6H 2 O, CAS: 10196-18-6), ammonium fluoride (NH 4 F, CAS: 12125-01-8), cetyltrimethylammonium bromide (CTAB, CAS: 57-09-0), zinc chloride (ZnCl 2 , CAS: 7646-85-7), copper chloride (CuCl 2 , CAS: 10125-13-0), and sodium silicate (Na 2 SiO 3 , CAS: 13517-24-3) were purchased from Sinopharm Chemical Reagent Co., Ltd (Shanghai, China)
Reducing exposure while maintaining effectiveness represents a reasonable risk reduction strategy for those concerned about theoretical cancer risk
The effects of hypoxia on the immune-metabolic interplay in liver cancer
Both plasma basic carboxypeptidases, carboxypeptidase B2 and carboxypeptidase N, regulate vascular leakage activity in mice
310 This finding underscores the close interconnection between uric acid and nitric oxide regulation in this particular clinical context
